- Lobbying
- Lobbying by Association of Clinical Research Organizations
Lobbying Relationship
Bills mentioned
H.R.6: 21st Century Cures Act
Sponsor: Fred Upton (R-Mich.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Douglas Peddicord | n/a |
Katherine L. Madigan | n/a |
John J. Lewis | n/a |
Peter Banks | n/a |
Leila Mendelovici | n/a |
John Lewis | n/a |
Sabah Bhatnagar | n/a |
Sophia McLeod | n/a |
Brett Adelman | n/a |
Scott Haber | n/a |
Doug Peddicord | n/a |
Karen Noonan | n/a |
Kyle Peddicord | n/a |
Katherine Madigan | n/a |
Leslie Irvine | n/a |
John J Lewis | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Natl Institutes of Health (NIH)
Health & Human Services - Dept of (HHS)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Natl Institutes of Health (NIH)
Health & Human Services - Dept of (HHS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Natl Institutes of Health (NIH)
Health & Human Services - Dept of (HHS)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Natl Institutes of Health (NIH)
Health & Human Services - Dept of (HHS)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Government Accountability Office (GAO)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Food & Drug Administration (FDA)
Natl Institutes of Health (NIH)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Food & Drug Administration (FDA)
Natl Institutes of Health (NIH)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Food & Drug Administration (FDA)
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Food & Drug Administration (FDA)
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Food & Drug Administration (FDA)
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Registration
Issue(s) they said they’d lobby about: conduct of clinical trials
protection of human reserach subjects
FDAAA
Drug Safety.
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate